GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Australian Clinical Labs Ltd (ASX:ACL) » Definitions » Common Stock

Australian Clinical Labs (ASX:ACL) Common Stock : A$792.1 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Australian Clinical Labs Common Stock?

Australian Clinical Labs's quarterly common stock stayed the same from Dec. 2022 (A$792.1 Mil) to Jun. 2023 (A$792.1 Mil) and stayed the same from Jun. 2023 (A$792.1 Mil) to Dec. 2023 (A$792.1 Mil).

Australian Clinical Labs's annual common stock declined from Jun. 2021 (A$798.0 Mil) to Jun. 2022 (A$793.0 Mil) and declined from Jun. 2022 (A$793.0 Mil) to Jun. 2023 (A$792.1 Mil).


Australian Clinical Labs Common Stock Historical Data

The historical data trend for Australian Clinical Labs's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Australian Clinical Labs Common Stock Chart

Australian Clinical Labs Annual Data
Trend Dec20 Jun21 Jun22 Jun23
Common Stock
47.10 797.98 793.03 792.14

Australian Clinical Labs Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Common Stock Get a 7-Day Free Trial 793.03 793.03 792.14 792.14 792.14

Australian Clinical Labs Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Australian Clinical Labs (ASX:ACL) Business Description

Traded in Other Exchanges
N/A
Address
1868-1892 Dandenong Road, Clayton, VIC, AUS, 3168
Australian Clinical Labs, or ACL, is Australia's third-largest private pathology provider. ACL earns almost its entire group revenue from pathology services in Australia, which are mostly earned via the publicly funded health Medicare system. ACL is well-established in the states of Western Australia, South Australia, Victoria and the Northern Territory.

Australian Clinical Labs (ASX:ACL) Headlines

No Headlines